Bo Feldt‐Rasmussen

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Colin Baigent, Martin Landray, Christina Reith et al. · The Lancet · 2011 · 2.4K citations

Cardiovascular Disease, Medicine, Antihypertensive Therapy +6

Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes

Klaus Klausen, Knut Borch‐Johnsen, Bo Feldt‐Rasmussen et al. · Circulation · 2004 · 690 citations

EFFECT OF TWO YEARS OF STRICT METABOLIC CONTROL ON PROGRESSION OF INCIPIENT NEPHROPATHY IN INSULIN-DEPENDENT DIABETES

Bo Feldt‐Rasmussen, E. R. Mathiesen, T. Deckert · The Lancet · 1986 · 452 citations

Obesity, Metabolic Syndrome, Renal Function +10

Urinary Albumin Excretion

Knut Borch‐Johnsen, Bo Feldt‐Rasmussen, Svend Strandgaard et al. · Arteriosclerosis Thrombosis and Vascular Biology · 1999 · 438 citations

Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease

Jan Skov Jensen, Bo Feldt‐Rasmussen, Svend Strandgaard et al. · Hypertension · 2000 · 424 citations